Pipeline
A tracked areas dataset for our medical research coverage: what it measures, where the figures come from and when they were last checked.
Star Therapeutics secures $200 million to refocus pipeline
Star Therapeutics announced a $200 million venture capital financing round on October 23, 2026, to advance its rare disease biologics pipeline...
Moonwalk Biosciences pivots to RNAi obesity drugs with $70M
Moonwalk Biosciences has raised $70 million in Series B funding to advance a pipeline of RNA interference drugs for obesity.
ADARx files for IPO to fund three clinical-stage siRNA medicines
ADARx Pharmaceuticals has filed for an initial public offering to raise funds for advancing its pipeline of siRNA therapies.